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Abstract
Intracellular signaling pathways that are involved in protec-
tion of vascular smooth muscle cells (VSMC) from apoptosis
remain poorly understood. This study examines the effect of
activators of cAMP/cGMP signaling on apoptosis in non-
transfected VSMC and in VSMC transfected with c-myc
(VSMC-MYC) or with its functional analogue, E1A-adenoviral
protein (VSMC-E1A). Serum-deprived VSMC-E1A exhibited
the highest apoptosis measured as the content of chromatin
and low molecular weight DNA fragments, phosphatidylserine
content in the outer surface of plasma membrane and
caspase-3 activity (ten-, five-, four- and tenfold increase after
6 h of serum withdrawal, respectively). In VSMC-E1A, the
addition of an activator of adenylate cyclase, forskolin,
abolished chromatin cleavage, DNA laddering, caspase-3
activation and the appearance of morphologically-defined
apoptotic cells triggered by 6 h of serum deprivation. In non-
transfected VSMC and in VSMC-MYC, 6 h serum deprivation
led to *six- and threefold activation of chromatin cleavage,
respectively, that was also blockedby forskolin. In VSMC-E1A,
inhibition of apoptosis was observed with other activators of
cAMP signaling (cholera toxin, isoproterenol, adenosine, 8-
Br-cAMP), whereas 6 h incubation with modulators of cGMP
signaling (8-Br-cGMP, nitroprusside, atrial natriuretic peptide,
L-NAME) did not affect the development of apoptotic
machinery. The antiapoptoticeffectof forskolinwas abolished
in 24 h of serum deprivation that was accompanied by
normalization of intracellular cAMP content and protein
kinase A (PKA) activity. Protection of VSMC-E1A from
apoptosis by forskolin was blunted by PKA inhibitors (H-89
and KT5720), whereas transfection of cells with PKA catalytic
subunit attenuated apoptosis triggered by serum withdrawal.
The protection of VSMC-E1A by forskolin from apoptosis was
insensitive to modulators of cytoskeleton assembly (cytocha-
lasin B, colchicine). Neither acute (30 min) nor chronic (24 h)
exposure of VSMC to forskolin modified basal and serum-
induced phosphorylation of the MAP kinase ERK1/2. Thus, our
results show that activation of cAMP signaling delays the
development of apoptosis in serum-deprived VSMC at a site
upstream of caspase-3 via activation of PKA and indepen-
dently of cAMP-induced reorganization of the cytoskeleton
network and the ERK1/2-terminated MAPK signaling cascade.
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Introduction
Both vascular smooth muscle cell (VSMC) growth and
programmed cell death contribute to the altered geometry of
vessels in hypertension,1,2 the development of artherosclero-
tic plaques3,4 and regression of vascular hypertrophy under
treatment of cardiovascular complications of these diseases.5
Much is known about the pharmacological regulation of
VSMC replication (for review see6,7), which is in contrast with
the lack of systematic studies on the pharmacology of VSMC
apoptosis. Similarly to the majority of cells investigated so far,
apoptosis in VSMC can be triggered by the withdrawal of
growth factors.1,4,8 The ligands of Fas/Apo-1/CD95, a novel
member of the tumor necrosis factor (TNF) receptor family,
trigger apoptosis in p53-transfected VSMC9 as well as in
VSMC from human atherosclerotic plaques subjected to
chronic exposure to T lymphocyte-derived interferon-g,
macrophage-derived TNF and interleukin-110,11 but do not
affect apoptosis in VSMC from normal vessels.9,11 Apoptosis
in serum-deprived VSMC is potentiated by overexpression of
c-myc, E1A adenovirus, co-expression of p53 with c-myc/
E1A, and is inhibited by overexpression of bcl-2.4,8,12
However, intracellular signaling pathways controlling the
expression and functional activity of these gene products
are poorly understood.
It is well-documented that bcl-2, p53 as well as gene
products involved in cell cycle progression, such as
retinoblastoma gene product, cyclins and cyclin-dependent
proteases and phosphatases, are subjected to serine/
threonine phosphorylation,13 – 15 suggesting the role of
serine/threonine protein kinases, including cyclic nucleo-
tide-dependent protein kinases, in the regulation of
apoptotic machinery. To motivate our study, it is important
to underline that data on the involvement of cAMP and
cGMP signaling systems in apoptosis demonstrate an
extreme tissue-specificity and dependence on the origin
of apoptotic stimulus. In the majority of studies, including
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myeloid leukemia cells,16 primary granulosa cells,17
thymocytes,18 – 20 embryonic epithelial cells,21 elevation of
cAMP triggered apoptosis, whereas in neutrophils and
nerve tissue, it prevented the development of apoptotic
machinery.22 – 24 In T lymphocytes, activation of cAMP
signaling did not affect CD95-induced apoptosis as well as
apoptosis induced by etoposide, dexamethasone and
thapsigargin, whereas activation of cGMP-dependent
protein kinase (PKG) partially inhibited CD95-induced
apoptosis.25,26 On the contrary, in leukemic HL-60 cells,
apoptosis can be triggered by nitric oxide donors and
partially inhibited by cAMP.27 cGMP potentiated apoptosis
in neonatal rat cardiac myocytes but did not affect the
death of cardiac fibroblasts.28
This study specifically examines the role of cAMP and
cGMP signaling in the development of apoptosis in cultured
VSMC from the rat aorta. Our results show that activation
of cAMP signaling delays VSMC apoptosis by acting on a
step upstream of caspase-3. In contrast to cAMP, apoptosis
in VSMC is insensitive to activation of the cGMP signaling
pathway.
Results
Kinetics of chromatin cleavage in serum-deprived
cells
The study of cross-talk of signals involved in the induction and
progression of VSMC programmed death is complicated due
to the low activity of the apoptotic pathway in these cells.1,4 To
overcome this problem, we used cells transfected with c-myc
(VSMC-MYC) or its functional analogue, E1A-adenoviral
protein (VSMC-E1A). Previously, it was shown that in the
absence of growth factors these cells are still actively cycling
and undergo massive apoptosis.12
The initial content of chromatin fragments used as a
well-documented marker of apoptosis was about the same
in non-transfected VSMC as in VSMC-MYC and VSMC-
E1A (0.4 – 0.7%) and was increased after 24 h incubation in
the presence of 10% calf serum up to 2.51+0.32,
3.71+0.30 and 5.01+0.46% in VSMC, VSMC-MYC and
VSMC-E1A cells, respectively. In contrast to baseline
conditions, chromatin cleavage in serum-depleted medium
was drastically potentiated by transfection with c-myc and
E1A-adenovirus, reaching 4, 10 and 25% after 6 h of serum
deprivation in VSMC, VSMC-MYC and VSMC-E1A,
respectively (Figure 1a).
The drastic potentiation of apoptosis in serum-deprived
VSMC-E1A compared to non-transfected cells was
confirmed by analysis of DNA laddering (Figure 1b),
relative content of phosphatidylserine on the outer leaflet
of plasma membrane (Figure 2) and by morphological
evaluation of the appearance of apoptotic cells (Figures 3
and 4). Figure 1b shows that the content of low molecular
weight 3’-end labeled DNA fragments was higher by
*tenfold in serum-deprived VSMC-E1A compared to
non-transfected cells. Two populations of cells possessing
high and low fluorescent signal (HF- and LF-cells,
respectively) were revealed by annexin-V-Fluos binding
assay (Figure 2a and b). In non-transfected VSMC the
amount of HF-cells caused by enhanced content of
phosphatidylserine on the outer surface of plasma
membrane did not exceed *2% and was independent of
acute serum deprivation (data not shown). In contrast, the
content of high fluorescent VSMC-E1A was increased after
6 h of serum deprivation by *fourfold (Figure 2c). It
Figure 1 Apoptosis in non-transfected vascular smooth muscle cells (VSMC) and in VSMC transfected with c-myc (VSMC-MYC) or E1A-adenovirus (VSMC-E1A).
(a) Time-course of the accumulation of intracellular chromatin fragments in VSMC, VSMC-MYC and VSMC-E1A induced by serum withdrawal. Means+S.E. from
experiments performed in quadruplicate are given. (b) Effect of serum deprivation on DNA laddering (left panel) and relative content of low molecular weight
(1500 – 125 bp) 3’-end labeled DNA fragments (right panel) in VSMC and E1A-VSMC. Cells were incubated in the presence (+) or absence (7) of 10% calf serum
(CS) for 6 h. The content of low molecular weight DNA fragments in serum-deprived VSMC-E1A was taken as 100%. Data from three experiments are shown as
means+S.E. *P50.01 compared to control
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should be mentioned that baseline content of HF-cells
(Figure 2a) is probably overestimated due to partial
induction of apoptosis in VSMC-E1A under their trypsiniza-
tion and staining in serum-free medium.
Phase contrast microscopy did not reveal any significant
effect of 6 h serum deprivation on VSMC morphology
(Figure 3A and B). In contrast, serum deprivation of VSMC-
E1A led to drastic accumulation of rounded cells which
were preferentially localized in the incubation medium
(Figure 3D vs C). The detachment of the major part of
apoptotic cells was further confirmed by analysis of
Hoechst 33258-positive cells. The number of Hoechst-
positive VSMC attached to plastic support (5+2%) was not
significantly affected by 6 h serum deprivation, whereas in
VSMC-E1A this parameter was increased from 12+2 to
24+6% (Figure 4A panels a – c). Using serum-supplied and
serum-deprived VSMC, we did not observe Hoechst-
positive cells in the incubation medium; the negative result
was also obtained with serum-supplied VSMC-E1A (data
not shown). On the contrary, in serum-deprived VSMC-E1A
Figure 2 Analysis of the relative content of phosphatidylserine on the outer leaflet of VSMC-E1A using annexin V-Fluos. The representative distributions of cells
with low (LF) and high (HF) fluorescence in the presence of 10% calf serum and after 6 h of incubation in serum deprived medium are shown in panels (a) and (b),
respectively. (c) The relative content of HF-VSMC-E1A in the presence of serum and after 6 h of serum deprivation. The total content of HF- and LF-cells was taken
as 100%. Means+S.D. obtained in three experiments are given
Figure 3 Phase-contrast microscopy of VSMC (A, B) and VSMC-E1A (C, D) after 6 h of incubation in the presence of 10% calf serum (A, C) or in serum-deprived
medium (B, D). Apoptotic cells are shown by arrows
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virtually all cells in the incubation medium were stained with
Hoechst 33258 (Figure 4A panel d).
Keeping in mind the highest susceptibility of VSMC-E1A
to undergo apoptosis and the highest increase of chromatin
cleavage after 6 h of incubation, the effect of modulators of
cAMP/cGMP signaling on the content of chromatin
fragments in these cells and at this time-point have been
studied in the bulk of experiments. The major findings from
these experiments were further examined with VSMC-MYC
and non-transfected VSMC. The data on the preferential
localization of apoptotic cells in the incubation medium
were used for the study of apoptosis in cells transiently
transfected with PKA (see below).
Modulation of apoptosis by activators of cAMP and
cGMP signaling
The data presented in Table 1 show that the permeable
analogue of cAMP, 8-Br-cAMP, decreased chromatin
cleavage induced by 6 h incubation of VSMC-E1A in serum-
A
B
Figure 4 (A) Fluorescent microscopy of VSMC (a) and VSMC-E1A (b – d) attached to plastic support (a – c) or localized in the incubation medium (d) and stained
with Hoechst 33258. Cells were incubated during 6 h in the presence (b) or absence (a, c, d) of 10% calf serum. Hoechst-positive cells are shown by arrows. (B)
The relative amount of Hoechst-positive VSMC (a) and VSMC-E1A (b – d) attached to plastic support (a – c) or localized in the incubation medium (d) after 6 h
incubation in the presence (b) or absence (a, c, d) of 10% calf serum. Means+S.E. obtained in three experiments counted in 3 – 4 different areas are given
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deprived medium by 80 – 90%. Inhibition of apoptosis was
also observed under elevation of intracellular cAMP with an
inhibitor of phosphodiesterase, Ro-20 1724, an activator of
Gs-protein, cholera toxin, and an activator of adenylate
cyclase, forskolin. In VSMC, intracellular cAMP content can
also be increased via activation of b-adrenergic29 and A2-
adenosine receptors.30 Both adenosine and the b-adrenergic
agonist isoproterenol potentiated the antiapoptotic action of
Ro-20 1724. Drastic inhibition of chromatin cleavage with
forskolin, observed in VSMC-E1A, was also revealed in
VSMC-MYC and in non-transfected VSMC subjected to 6 h of
serum withdrawal (Table 1).
The antiapoptotic action of cAMP was further confirmed
by analysis of 3’-end DNA labeling and by phase contrast
microscopy. In serum-deprived VSMC-E1A, addition of
forskolin decreased the accumulation of low molecular
weight DNA fragments by 6 – 7-fold (Figure 5b) and
prevented the appearance of morphologically defined
apoptotic cells (Figure 5c). The cell shape transition
(arborization) seen in forskolin-treated serum-deprived
VSMC-E1A (Figure 5c, panel D) was consistent with data
obtained with non-transfected VSMC treated with forskolin
and other activators of cAMP signaling.31 – 33 In contrast to
cAMP, modulators of cGMP signaling, such as 8-Br-cGMP,
an inhibitor of nitric oxide synthase, L-NAME, and activators
of membrane-bound and soluble guanylate cyclase, atrial
natriuretic peptide (ANP) and nitroprusside, respectively, did
not significantly affect baseline and serum deprivation-
induced chromatin cleavage in VSMC-E1A (Table 2).
Caspase-3 activity
Using a substrate and inhibitor of the caspase-1 subfamily
(YVAD-AMC and Ac-YVAD-CHO, respectively), we did not
observe any activation of this enzyme in VSMC and VSMC-
E1A undergoing apoptosis (data not shown), whereas
caspase-3 activity was increased by tenfold after 6 h
incubation of VSMC-E1A in serum-depleted medium. For-
skolin decreased the baseline activity of caspase-3 and
sharply inhibited its increment induced by serum deprivation
(Table 3).
Role of protein kinase A
To examine the role of PKA in the inhibition of apoptosis by
activators of cAMP signaling, we (i) compared kinetics of
modulation by forskolin of chromatin cleavage, cAMP
production and PKA activation in VSMC-E1A and in non-
transfected VSMC; (ii) examined effect of protein kinase
inhibitors on apoptosis in VSMC-E1A; and (iii) transiently
transfected VSMC-E1A with catalytic subunit of PKA. Both in
VSMC-E1A and in non-transfected VSMC, the inhibition of
chromatin cleavage by an activator of adenylate cyclase,
forskolin, was abolished under prolonged (24 h) incubation
(Figure 6). The slight potentiation of apoptosis observed in
forskolin-treated cells after 24 h is in accordance with
previously reported data.1 This transient inhibition of
apoptosis by forskolin was consistent with transient elevation
of intracellular cAMP content and PKA activity and normal-
ization of these parameters after 24 h incubation (Figure 7).
The addition of potent inhibitors of PKA, KT 5720 and H-
89 (IC50 for PKA and PKG *0.05 and 0.5 mM, respec-
tively34 did not affect the content of chromatin fragments in
serum-supplied and serum-deprived VSMC-E1A, but
reduced the forskolin-induced inhibition of chromatin
cleavage in serum-deprived VSMC-E1A to 61 and 47%,
respectively, as compared with 81% of inhibition observed
in the absence of these compounds (Table 4). In contrast to
KT 5720 and H-89, apoptosis in forskolin-treated cells was
insensitive to the less potent inhibitor of PKA, compound H-
8 (IC50 for PKA, and PKG 1.2 and 0.5 mM, respectively
35).
To further examine the role of PKA in the inhibition of
apoptosis, we transiently transfected VSMC-E1A with
catalytic subunit of PKA. It should be underlined, however,
that low efficiency of transient transfection (*10 – 20%)
complicates the study of the effect of PKA on apoptosis in
the total population of cells. To overcome this problem, we
co-transfected VSMC-E1A with luciferase and compared the
intensity of luminescence in attached cells and in medium.
This approach is based on the observation that apoptotic
VSMC-E1A cells are mainly localized in the incubation
medium (Figures 3 and 4). Figure 8 shows that the intensity
of luminescence in medium from control and PKA-
transfected cells in the presence of calf serum was not
different, whereas an increment of luminescence triggered
by induction of apoptosis in serum-deprived medium was
*twofold less in VSMC-E1A transfected with PKA
compared to cells transfected with empty vector (25 and
47%, respectively, P50.02).
Role of cytoskeleton network and MAP kinases
Activation of cAMP signaling leads to transient shape
transition (arborization) of VSMC which is abolished after
Table 1 Effect of activators of cAMP signaling on chromatin cleavage in non-
transfected vascular smooth muscle cells (VSMC) and in VSMC transfected with
c-myc (VSMC-MYC) or E1A adenovirus (VSMC-E1A)
Chromatin fragments, %
Type of cells/additions 10% CS CS-free
VSMC-E1A
Control
8-Br-cAMP, 1 mM
Ro-20 1724, 20 mM
Cholera toxin, 0.5 mg/ml
Forskolin, 10 mM
Ro-20 1724+isoproterenol, 10 mM
Ro-20 1724+adenosine, 100 mM
2.7+0.5
3.0+0.5
2.8+0.4
2.1+0.4
1.9+0.6
2.1+0.8
2.2+0.6
23.4+2.8
6.1+0.8**
16.1+1.9*
8.3+2.2**
5.6+1.0**
11.5+2.7*
10.0+1.9*
VSMC-MYC
Control
Forskolin, 10 mM
2.2+0.4
1.9+0.3
13.1+1.8
2.6+0.3**
VSMC
Control
Forskolin, 10 mM
0.9+0.1
1.0+0.1
3.4+0.4
1.6+0.1*
Cells were preincubated with the compounds listed in the left column in the
presence of 10% calf serum (CS) during 30 min or 3 h (cholera toxin). Then, the
medium was aspirated and the cells were incubated for the next 6 h with the
same compounds in the presence or absence of calf serum. Data from three
experiments performed in triplicate are shown as mean+S.E. *P<0.05 and
**P<0.001, as compared to the controls (non-treated cells)
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normalization of intracellular cAMP content.29,31 – 33 Consider-
ing this, it may be assumed that the transient inhibition of
apoptosis in VSMC by cAMP (Figure 6) is mediated via
cytoskeleton reorganization. However, this assumption
contradicts several observations. Indeed, substances that
disintegrate actin filaments, such as cytochalasin B, cause
arborization of VSMC similar to that observed in cAMP-
treated VSMC, whereas colchicine, a substance interfering
with the assembly-disassembly of microtubules, prevents
cAMP-induced arborization of VSMC.29,31,32 However,
neither cytochalasin nor colchicine affected baseline apopto-
sis in VSMC-E1A and its modulation by forskolin (Table 5). In
addition, in contrast to non-transfected VSMC (Figure 5c),
VSMC-MYC did not undergo arborization in the presence of
c)
Figure 5 Effect of forskolin on apoptosis in serum-deprived VSMC-E1A. The cells were preincubated in the presence (+) or absence (7) of 10 mM forskolin and
10% calf serum (CS) for 6 h. (a) 3’-end DNA laddering and (b) relative content of low molecular weight (1500 – 125 bp) 3’-end labeled DNA fragments. The relative
amount of DNA fragments in serum-deprived VSMC-E1A in the absence of forskolin was taken as 100. Data from experiment performed in triplicate are shown as
means+S.E. *P50.01. (c) Phase-contrast microscopy of VSMC-E1A after 6 h of incubation in the presence of 10% calf serum (A, C) or in serum-deprived medium
(B, D) without (A, B) or with 10 mM forskolin (C, D). Apoptotic cells are shown by arrows
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Table 2 Effect of modulators of cGMP signaling on chromatin cleavage in
VSMC-E1A
Chromatin fragment, %
Additions, mM 10% CS CS-free
Control
8-Br-cGMP, 1
L-NAME, 2
ANP, 0.001
Nitroprusside, 0.5
3.0+0.5
2.8+0.5
3.2+0.7
3.1+0.3
4.8+1.0
24.7+3.0
23.9+2.7
24.3+2.8
23.4+3.2
31.1+4.8
Cell were preincubated with the compounds listed in the left column in the
presence of 10% calf serum (CS) for 30 min. Then, the medium was aspirated
and cells were incubated for the next 6 h with the same compounds in the
presence or absence of calf serum. Data from three experiments performed in
quadruplicate are shown as means+S.E.
Table 3 Effect of forskolin on caspase-3 activity in VSMC-E1A
Caspase-3 activity, nmol
(mg protein)–1 h–1
Additions
Serum-supplied
cells
Serum-deprived
cells
None (control)
Forskolin, 10 mM
0.36+0.21
0.08+0.03*
3.99+0.78
0.65+0.30*
Cells were incubated for 6 h in the presence or absence of 10% calf serum with
or without forskolin, and caspase-3 activity was measured in the cell lysate as
indicated in Materials and Methods. Data from three experiments performed in
triplicate are shown as means+S.E. *P<0.001 as compared with the control
Figure 6 Kinetics of modulation by forskolin (10 mM) of chromatin cleavage
triggered by serum deprivation in VSMC-E1A (a) and in non-transfected VSMC
(b). Data from two (VSMC) and three (E1A-VSMC) experiments performed in
quadruplicate are shown as means+S.E
Table 4 Effect of protein kinase inhibitors on chromatin cleavage in VSMC-E1A
Chromatin fragments, %
Additions, mM 10% CS CS-free
Control
H-89, 10
KT 5720, 5
H-8, 10
Forskolin, 10
H-89+forskolin
KT 5720+forskolin
H-8+forskolin
2.7+0.4
3.0+0.4
2.8+0.5
3.3+0.6
2.0+0.3
2.6+0.4
3.5+0.7
2.2+0.2
22.7+2.5
24.8+3.0
23.6+3.0
25.0+2.4
5.9+0.8***
12.0+1.6**
15.7+2.0*
20.7+2.6
Cells were preincubated with H-89, KT 5720 and H-8 in the presence of 10%
calf serum (CS) for 1 h. Then, the medium was aspirated and cells were
incubated for the next 6 h with the same compounds in the presence or absence
of calf serum and forskolin. Data from three experiments performed in
quadruplicate are shown as means+S.E. *P<0.05, **P<0.01 and ***P<0.001
as compared with the controls respectively
Figure 7 Kinetics of modulation of intracellular cAMP content (a) and protein
kinase A activity (b) by forskolin in VSMC. PKA activity was measured in the
absence (curve 1) or in the presence of 0.1 mM cAMP (curve 2) and 0.1 mM
cAMP+10 mM PKI (curve 3). The radioactivity of PKA substrate, Kemptide, in
control (forskolin-untreated cells) measured in the absence of cAMP and PKI
was taken as 100%. Data from experiments performed in triplicate are shown
as means+S.E
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forskolin (Figure 9D). This feature of VSMC-MYC is probably
related to the different organization of the cytoskeleton
network caused by fivefold depletion of these cells with
actin.12 However, despite the lack of cytoskeleton reorganiza-
tion, similarly to VSMC and VSMC-E1A, forskolin still
prevented chromatin cleavage in serum-deprived VSMC-
MYC (Table 2). Neither acute nor chronic exposure to
forskolin modified phosphorylation of ERK1 (p42) and ERK2
(p44) MAP kinases (Figure 10).
Discussion
Data obtained in this study show for the first time that
activation of cAMP signaling transiently inhibits apoptosis in
serum-deprived VSMC. In contrast to cAMP, elevation of
intracellular cGMP caused by 8-Br-cGMP or ANP did not
affect VSMC apoptosis. The addition of nitroprusside for 6 h
slightly potentiated chromatin cleavage in VSMC-E1A (Table
2). Recently, it has been reported that 48 – 96 h treatment of
VSMC from the rat and human aorta with NO donors including
nitroprusside leads to accumulation of apoptotic cells.36,37
However, this effect was caused by cGMP-independent
activation of the expression of Fas-ligand receptor36,
reduction of free radical scavengers37 or expression of
c-myc and p53.38
The antiapoptotic time window observed in forskolin-
treated VSMC coincided with the kinetics of cAMP
production and activation of PKA (Figures 6 and 7).
Inhibition of apoptosis by forskolin was also diminished in
the presence of the inhibitors of PKA, H-89 and KT-5720,
and was insensitive to the PKG inhibitor, H-8 (Table 4).
Moreover, similar to cAMP-rising compounds, transfection
of VSMC-E1A with catalytic subunit of PKA diminished
Figure 8 Effect of PKA on apoptosis in VSMC-E1A. Cells were co-
transfected with luciferase and pFC empty vector (a) or with pFC
containing catalytic subunit of PKA (b) as described in the Materials and
Methods section. In 36 h, cells were washed and incubated in the
presence of 10% calf serum (CS) or in CS-free DMEM. In 6 h, medium
was transferred into tubes, centrifuged (8006g, 5 min) and pellet as well
as cells remaining on plates were washed twice with PBS. Then, cells
were lysed in 250 ml of Mammalian Protein Extraction Reagent (M-PERTM,
Pierce, Rockford, IL, USA), cleared by centrifugation and 20 ml of lysates
were used for the measurement of luminescence in cells from medium
(Ilum) and from plates. The total values of luminescence of detached and
attached cells were taken as 100%. Data from experiment performed in
triplicate are shown as means+S.E
Figure 9 Phase-contrast microscopy of control (A, B) and forskolin-treated (C, D) non-transfected cells (VSMC; A, C) and c-myc-transfected cells (VSMC-MYC;
B, D)
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apoptosis triggered by serum withdrawal (Figure 8).
Considering this, it may be concluded that the antiapopto-
tic action of the cAMP signaling pathway is mediated via
activation of PKA.
In the majority of cells studied so far, activation of
cysteine proteases of the caspase superfamily is viewed as
‘a point of no return’ in the development of apoptotic
machinery.39 However, data on the involvement of
caspases in VSMC apoptosis are limited to a few
publications showing cleavage of procaspase-3 after 6 h
treatment of VSMC-E1A in serum-deprived medium40 or
after chronic treatment of VSMC with NO donors.38 Here,
we report that after 6 h serum deprivation of VSMC-E1A,
caspase-3 activity was enhanced by tenfold. Both the
baseline activity of this enzyme and its increment triggered
by serum deprivation were sharply decreased in forskolin-
treated cells (Table 3). We did not observe any modulation
of caspase-3 activity in VSMC-E1A lysate by additions of
cAMP (0.5 mM) and catalytic subunit of protein kinase A
(1 U/ml) in the presence of 0.5 mM ATP (data not shown).
These results strongly suggest that the cAMP/PKA-
sensitive step of development of the apoptotic machinery
in VSMC is located upstream of caspase-3.
Several mechanisms can be proposed by the analysis of
data on the antiapoptotic action of activators of cAMP
signaling in VSMC. Thus, the cAMP-induced delay of
apoptosis may be caused by transient reorganization of
cytoskeleton network seen in VSMC treated with activators
of cAMP signaling.29,31 – 33 However, this hypothesis should
be probably ruled out because of the lack of effect of
modulators of cytoskeleton assembly on VSMC apoptosis
in the absence or presence of forskolin (Table 5) and the
same level of inhibition of apoptosis in VSMC-MYC by
forskolin despite the lack of forskolin-induced cytoskeleton
reorganization in these cells (Figure 9).
Induction of apoptosis by c-myc is linked with the
continuation of cell cycling in the absence of growth
factors.12 Considering this, it may be assumed that
inhibition of apoptosis by cAMP may be mediated by
modulation of MAPK signaling cascade involved in the
regulation of VSMC proliferation and cell cycle progres-
sion.41 This hypothesis is based on the transient PKA-
dependent suppression by cAMP of Ras-dependent
activation of MAPKK kinase Raf-1 observed in several
fibroblast cell lines.42 Recently, however, it was shown that
in contrast to these observations, angiotensin II-induced
ERK1/ERK2 phosphorylation and MAPK activity are not
affected by 30 min preincubation of VSMC with forskolin,43
indicating the lack of involvement of this signaling pathway
in angiotensin II-induced protein synthesis and hypertrophy.
The data obtained in the present study demonstrate that
neither acute (30 min) nor chronic (24 h) treatment of
VSMC with forskolin significantly affects the baseline
content and phosphorylation of ERK1/ERK2 as well as
Figure 10 Phosphorylation of MAP kinase (aERK) in the presence and absence of calf serum and forskolin. VSMC were serum starved for 2 days in DMEM
containing 0.1% BSA. In some of the samples, forskolin was added for 24 h or during the last 0.5 h of preincubation as indicated. Then, these media were aspirated
and DMEM with or without 10% calf serum was added for an additional 10 min. MAPK phosphorylation was determined by gel retardation using anti-p42 ERK
antibodies (A), or by immunoblotting with phospho-specific anti-p42/p44 ERK antibodies (B)
Table 5 Effect of forskolin on apoptosis in VSMC-E1A in the presence of
modulators of cytoskeleton assembly
Chromatin fragments, %
Additions, mM 10% CS CS-free
Control
Cytochalasin B, 10
Colchicine, 40
Forskolin, 10
Cytochalasin B+forskolin
Colchicine+forskolin
3.1+0.6
2.9+0.3
3.3+0.6
1.9+0.4
2.1+0.3
1.8+0.5
25.9+3.5
22.7+2.8
21.5+4.3
6.5+0.8*
6.3+0.5*
7.6+0.9*
Cells were preincubated with cytochalasin B or colchicine in the presence of
10% calf serum (CS) for 30 min. Then, the medium was aspirated and cells were
incubated for the next 6 h with the same compounds in the presence or absence
of calf serum and forskolin. Data from two experiments performed in
quadruplicate are shown as mean+S.E. *P<0.001 as compared to the controls
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the induction of phosphorylation of these proteins by brief
exposure to calf serum (Figure 10). These results show that
the MAPK cascade, terminated by activation of ERK1/
ERK2, is not involved in the transient inhibition of apoptosis
by forskolin.
In conclusion, the results obtained in this investigation
show that activation of cAMP signaling transiently inhibits
apoptosis in VSMC. This inhibitory effect is mediated by
PKA, is independent of cAMP-induced cytoskeleton
reorganization and MAPK ERK1/2, and affects a step
upstream of caspase-3. The role of other members of
MAPK signaling cascade, including the stress-regulated
MAPK p38 and JNK, as well as bcl-2, p53 and cyclin-
dependent kinases and phosphatases subjected to
phosphorylation-dephosphorylation cycle in the inhibition
of VSMC apoptosis by cAMP should be examined further.
Materials and Methods
Cultured VSMC
VSMC were obtained by explant methods from aortas of 10 – 13-week-
old male Brown Norway (BN.1x) rats in accordance with previously-
described methods.44 VSMC-MYC and VSMC-E1A constitutively
expressing c-myc and E1A-adenoviral protein8,12 were kindly
provided by Dr. MR Bennett (University of Cambridge, UK). VSMC
morphology was evaluated by phase contrast microscopy without
preliminary fixation. Micrographs were produced using a Nikon phase
contrast microscope and fluorescent microscope (Leica) at 6100
magnification.
Cell transfection
VSMC-E1A growing in 12-well plates were co-transfected with 0.5 mg/
well luciferase expression vector (Promega, Madison, WI, USA) and
1.5 mg/well of empty pFC vector or vector containing catalytic subunit
of protein kinase A (pFC-PKA, Stratagene, La Jolla, CA, USA).
Transfection was performed for 3 h in the presence of 5% calf serum
using LipofectAMINEPLUS reagent (Gibco, BRL) following standard
manufacturer’s protocol. Then, medium was aspirated and cells were
incubated during 36 h in DMEM containing 10% calf serum. The
efficiency of transfection was estimated by analysis of luciferase
luminescence using Luciferase Assay Reagent (Promega). For more
details see Figure 8.
Chromatin cleavage assay
Previously-described method45 with minor modifications listed below
was used in this study. Cells in 24-well dishes were supplied with 1 ml
of DMEM containing 10% calf serum and 1 mCi/ml [3H]-thymidine.
After 24 h, they were washed with 262 ml of DMEM and incubated in
DMEM with 10% CS. In 48 h, the cells were washed again and
incubated with DMEM containing 10% calf serum or with serum-
depleted DMEM. At the time intervals indicated in figure and table
legends, the medium was transferred and centrifuged at 9006g for
10 min. The supernatant was then transferred for the measurement of
radioactivity (fraction F1), and the cell pellet was treated for 15 min
with ice-cold lysed buffer (10 mM EDTA, 10 mM Tris-HCl, 0.5% Triton
X-100 (pH 8.0)). Cells remaining in wells were treated with lysed buffer
under the same protocol. Next, the cell lysates were combined,
sedimented (12 000 r.p.m., 10 min) and the supernatant was
transferred for the measurement of radioactivity (fraction F2). The
remaining radioactivity from the pellets and wells was extracted with
1% SDS/4 mM EDTA mixture (fraction F3). Radioactivity of samples
was measured in a liquid scintillation spectrometer, and the relative
content of intracellular chromatin fragments (F26(F1+F2+
F3)
716100%) was determined as a percentage of the total amount
of 3H-labeled DNA.
DNA isolation and 3’ end labeling
The incubation medium was aspirated, and cells seeded in 75 cm2
flasks were treated with 4 ml of lysis buffer containing 50 mM Tris-HCl,
20 mM EDTA (pH 8.0), 0.5% SDS and 500 mg/ml proteinase K. The
lysate was then incubated at 508C for 3 h and additionally for 1 h at
378C in the presence of 250 mg/ml RNase A. After phenol-chloroform
extraction, DNA was precipitated by the addition of a mixture
containing 0.5 M potassium acetate and ethanol (1 : 2 v:v). The
precipitate was resuspended in water, and DNA was estimated by
spectrophotometry at 260 nm. 3’-end DNA labeling with terminal
deoxynucleotidyl transferase (tdt) was performed as described in
detail previously.1 Briefly, 1 mg of DNA was mixed with a solution,
containing 2 mM CoCl2, 0.2 mM dithiothreitol, 100 mM potassium
cacodilate, 0.5 mM [32P]-dCTP (3000 Ci/mmol) and 15 U/ml tdt for a
final volume of 20 ml. After 1 h incubation at 378C, aliquots containing
0.2 mg DNA were loaded on 1.5% agarose gel, run at 100 V for 3 – 4 h,
transferred onto a nylon membrane (Hybond N+, Amersham), and
analyzed with a PhosphorImager (Molecular Dynamics, CA, USA).
Staining with Hoechst 33258
To visualize apoptotic nucleus, VSMC-E1A cells seeded in 6-well
plates were treated for 8 h in serum-deprived medium. Then, medium
was transferred into tubes, detached cells were sedimented
(1200 r.p.m., 5 min), washed twice with PBS, stained for 10 min with
Hanks’ balanced salt solution containing 50 ng/ml Hoechst 33258,
washed twice again and transferred on Superfrost/Plus slides (Fisher,
Neopon, ON, Canada). Cells remaining on plates were washed with
PBS, stained for 10 min with the same Hoechst 33258 solution and
washed with PBS.
Detection of phosphatidylserine on the outer
leaflet of apoptotic cells
VSMC-ElA seeded in 25 cm2 flasks were subjected to 6 h of serum
deprivation. Then, medium was aspirated and cells were treated
during 5 min at 378C with 0.05% trypsin (Gibco Laboratories) in Ca2+-
and Mg2+-free Dulbecco’s phosphate buffered saline. Trypsinization
was terminated by the addition of 10% calf serum and suspension was
combined with previously aspirated medium. The cells were
sedimented (1200 r.p.m., 8 min, 48C), washed twice with ice-cold
medium A containing 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM
CaCl2, 5 mM D-glucose and 20 mM HEPES-Tris (pH 7.4), counted,
and the volume was adjusted with the same medium to reach a final
concentration 107 cells/ml. Aliquots containing 106 cells were washed
with PBS and labeled with annexin-V-Fluos (Boehringer, Mannheim,
Indianapolis, IN, USA) in medium containing 140 mM NaCl, 5 mM
CaCl2 and 10 mM HEPES-NaOH (pH 7.4), following the manufac-
turer’s instructions. The relative amount of annexin-labeled cells was
determined on a flow cytometer (Becton-Dickinson, Franklin Lakes,
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NJ, USA) at excitation and emission wavelengths 488 and 515 nm,
respectively. To adjust cytometer for non-specific annexin binding,
5 mM CaCl2 was substituted with 0.2 mM EGTA.
Caspase activity
Cells growing in 20 cm2 plates were transferred onto ice, scratched
with a rubber policeman, sedimented at 10006g for 5 min at 48C, and
washed twice with medium containing 140 mM NaCl, 5 mM KCl, 1 mM
MgCl2, 1 mM CaCl2, 5 mM glucose, 20 mM HEPES-Tris buffer
(pH 7.4). The pellet was frozen in liquid nitrogen and kept at
7808C. Before the measurement of caspase activity, it was
resuspended in 0.5 ml of ice cold lysate buffer A containing 50 mM
Tris-HCl, 1 mM EGTA, 5 mM MgCl2 and 0.1% CHAPS (pH 7.4), and
kept on ice. To measure caspase activity, 50 ml of cell lysate were
added to 450 ml of lysate buffer A containing 1 mM dithiothreitol,
40 mM DEVD-AMC with or without 1 mM of the caspase-3 inhibitor Ac-
DEVD-CHO. After 2 h of incubation at 378C, the reaction was stopped
by transfer of 200 ml of protein suspension into 600 ml of 0.4 M glycine-
NaOH buffer (pH 10.0). Before measurement, the samples were
diluted by fourfold with water, and fluorescence was measured at
lex=365 nm and lem=465 nm (slits 4 and 20 nm, respectively). The
fluorescent signal was calibrated with AMC in the range from 0.01 –
0.3 mM. Protein content in the cell lysate was measured by the
Bradford method. Caspase-3 activity was calculated as a difference of
DEVDase activity in the absence and presence of Ac-DEVD-CHO.
cAMP content
Cells seeded in 12-well plates were incubated in DMEM containing
10% calf serum without or with forskolin. At the time intervals indicated
in Figure 3, the medium was aspirated, the cells were washed with
262 ml of medium containing 150 mM NaCl, 20 mM HEPES-Tris
buffer, pH 7.4, at 208C, and intracellular cAMP was extracted with 1 ml
of 1 N perchloric acid. cAMP content was determined by radio-
immunoassay.46 Protein content was measured by the Lowry method.
Protein kinase A activity
Digitonin-permeabilized VSMC loaded with a PKA specific substrate
Kemptide were used in this study.47 Control and forskolin-treated cells
seeded in 6-well plates were washed once with PBS and incubated for
10 min in 1 ml of medium containing 140 mM NaCl, 5 mM MgCl2,
0.2 mM EGTA, 0.1 mM [32P-g]-ATP (*700 c.p.m./pmol), 0.1 mM
Kemptide, 0.04% digitonin+0.1 mM cAMP and 10 mM PKA inhibitor
(PKI 6 – 22 amide). This medium was aspirated, cells were treated with
0.5 ml of 10% trichloroacetic acid, cell lysate was centrifuged
(12 000 r.p.m., 10 min, 28C) and supernatant was transferred onto
the manifold, holding 12 Whatman P811 disks which were washed four
times with 70 mM phosphoric acid, once with absolute ethanol and
counted.48
MAPK phosphorylation
Serum-starved VSMC grown in 6-well plates were preincubated with
forskolin, stimulated with 10% calf serum for 10 min, washed twice
with ice-cold phosphate-buffered saline and lysed in 150 ml of buffer
containing 25 mM HEPES-NaOH (pH 7.5), 150 mM NaCl, 1.5 mM
MgCl2, 1 mM EGTA, 10% Triton X-100, 1 mM phenylmethylsulphonyl
fluoride, 1 mg/ml leupetin, 1 mg/ml aprotinin, 200 mM Na-orthovanadate
and 1 mM NaF. The lysed cells were scraped, centrifuged at
14 000 r.p.m. for 20 min, and an equal volume of clear lysates
containing 20 mg of protein was applied on 10% polyacrylamide gel,
followed by electrophoresis and transfer to Immobilon-P membrane
(Millipore Corp., Bedford, MA, USA). Phosphorylation of p42/p44
MAPK was determined by Western blot analysis with antibodies
against phospho-ERK, following the manufacturer’s instructions and
documenting the electrophoretic mobility shift of phosphorylated
MAPK, using anti-p42 ERK antibodies. Protein content in the cell
lysate was measured by the Bradford method.
Chemicals
[3H]-thymidine – Amersham (Mississauga, ON, Canada); [32P-g]-ATP
– Amersham (Cleveland, OH, USA); H-8, H-89, KT 5720, cholera
toxin, protein kinase A inhibitor (PKI 6-22 amide) – Calbiochem
Novabiochem (La Jolla, CA, USA); sodium nitroprusside, L-NAME –
RBI (Natick, MA, USA); cAMP, 8-Br-cAMP, 8-Br-cGMP, catalytic
subunit of protein kinase A, Kemptide – Sigma (St. Louis, MO, USA);
phospho-ERK antibodies – New England Biolab Inc. (Beverly, MA,
USA); 7-amino-4-methylcoumarin (AMC) – Molecular Probes
(Eugene, OR, USA); DEVD-AMC (N-acetyl-Asp-Glu-Val-Asp-AMC),
DEVD-CHO – BIOMOL Research Laboratories (Plymouth Meeting,
PA, USA). Anti-p42 ERK antibodies were kindly provided by Dr.
Michael J Dunn (Medical College of Wisconsin, Milwaukee, WI, USA).
The remaining chemicals were obtained from Sigma, Gibco BRL
(Gaithersburg, MD, USA) and Anachemia (Montreal, QC, Canada).
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